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Abstract
Background: Ex vivo whole blood stimulation assays (WBSA) have been used to characterize the cytokine response
to diet in cats. The present study aimed to use this assay to determine the cytokine response to diets being fed at
the time of diagnosis to dogs with chronic enteropathy (CE) and to compare this to a control group of dogs
presented for non-gastrointestinal (GI) causes.
Results: Dogs with chronic GI signs and dogs presented for non-GI causes were prospectively recruited. For each
case, residual blood following diagnostic sampling was placed into heparin. WBSAs were performed using crude
extracts of the diet currently being fed and provided by the owner. Supernatants were collected and analyzed for
tumor necrosis factor (TNF)-alpha, interleukin (IL)-10 and IL-4 using an enzyme-linked immunosorbent assay. The
case group consisted of 22 dogs with CE diagnosed on histopathology of GI biopsy and 9 with suspected CE. The
non-GI group consisted of 18 dogs. Of the diets being fed at or prior to diagnosis, hydrolyzed protein diets elicited
significantly lower IL-10 and TNF-alpha concentrations compared to commercial intact protein diets in dogs with
confirmed or suspected CE (P-value 0.004 and < 0.001, respectively). Six out of 15 dogs with detectable IL-4
concentrations in the confirmed CE group had IL-4 to IL-10 ratios that exceeded the 95% confidence interval (CI) of
the mean of the non-GI group (non-GI: 95% CI of IL-4:IL-10 = 0.64–2.71; confirmed CE: IL-4:IL-10 in 6 dogs = mean
22.40, range 2.77–89.11).
Conclusions: Hydrolyzed protein diets elicited a significantly reduced cytokine response when incubated with
patient whole blood ex vivo compared to commercial intact protein diets in dogs with CE. The IL-4 to IL-10 ratio as
a marker of dietary responsiveness warrants further investigation, together with assessment of the cytokine
response to diet at the intestinal mucosal surface.
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Background
Food-responsive enteropathy (FRE) is a sub classification
of chronic enteropathy (CE) and describes a group of dis-
eases resulting in chronic gastrointestinal (GI) signs that
are responsive to dietary management alone; the under-
lying etiology of these diseases is unknown [1]. The diag-
nosis of FRE is made based on the dog’s response to an
exclusion diet trial. Dogs with true GI food allergy can
present with similar clinical signs to dogs with FRE. Inter-
estingly, studies have shown that intestinal histopathology
pre and post treatment with a successful diet trial in dogs
with FRE doesn’t change [2, 3], which suggests that the
pathogenesis of FRE and food allergy is different. Gastro-
intestinal food allergy can be subdivided into 2 major cat-
egories; immunoglobulin (Ig) E-mediated, which involves
mainly mast cells, and non-Ig E mediated, mainly involv-
ing T-cells and eosinophils [4]. Unfortunately, intradermal
skin testing, skin patch testing and measuring circulating
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food allergen-specific serum Ig E are of no diagnostic
value in GI food allergy due to their low sensitivity and
specificity [5, 6]. Therefore food trial and challenge is cur-
rently the gold standard for the diagnosis of GI food al-
lergy. Unfortunately, the differentiation of FRE from GI
food allergy in dogs is not definitively possible at this time.
Although, the return of clinical signs following challenge
with the original diet suggests GI food allergy, CE cannot
be definitively ruled out as these dogs may also relapse
due to individual dietary risk factors.
Similarly, dogs with FRE cannot be definitively differenti-
ated from enteropathy requiring steroid treatment based on
history, clinical signs, laboratory parameters or the severity
of GI endoscopic or intestinal histological lesions and there-
fore food trial is currently needed to differentiate the two
conditions. As the etiology of FRE is unknown, dogs may re-
spond to different dietary strategies necessitating trials with
multiple therapeutic diets before this condition can be ruled
out. This may result in frustration and be costly for the
owner as well as delay other treatment modalities such as
steroids, to which the dog may respond. Therefore, further
research is needed to try to differentiate FRE from steroid re-
sponsive enteropathy (SRE), as well as from GI food allergy.
The ability to differentiate dogs with FRE, SRE and GI food
allergy is also important to advance our knowledge of the
pathogenesis of individual chronic GI diseases, as this may
lead to novel, more efficacious treatments for these separate
diseases or change the way we currently treat them. Also,
the ability to differentiate FRE from SRE in dogs at the time
of diagnosis may help to avoid multiple unnecessary exclu-
sion diet trials.
The author has previously published a study in healthy
immunotolerant colony cats using sterile preparations of com-
mercial dry diets to stimulate whole blood ex vivo and meas-
ure cytokine production in the supernatant following
incubation for 24 h [7]. These stimulation assays used whole
blood instead of peripheral blood mononuclear cells (PBMCs)
in order to replicate the natural environment of the cells, to
prevent changes in phenotype that may occur with isolation
of the cells and to minimize the volume of blood needed, as
well as the processing time. This methodology using whole
blood has been shown to be comparable with the use of
PBMCs [8]. The study documented that the majority of cats
produced a detectable amount of interleukin (IL)-10 when
stimulated with a diet that they had previously tolerated.
Interleukin-10 is an anti-inflammatory cytokine and is pro-
duced by both the innate and adaptive immune system.
Interleukin-10 inhibits cytokines belonging to both the Th1
and Th2 pathways, as well as the expression of autoimmune
and pro-inflammatory conditions [9]. One study documented
that natural tolerance to foods was associated with increased
amounts of IL-10 producing PBMCs in humans [10]. A fur-
ther study suggested a role for serum IL-10 in the diagnosis of
food tolerance in humans [11]. Similarly, the results from the
author’s study suggested that increases in IL-10 production in
ex vivo whole blood stimulation assays may be used as a
marker of tolerance to diet in companion animals [7]. Studies
have shown an increase in IL-4 and a decrease in IL-10 con-
centrations in food-induced GI disorders in humans and mice
[12–14]. Interleukin-4 is the signature cytokine for the Th2
immune response and is one of the key cytokines involved in
inflammation triggered by allergens [15]. An increase in the
pro-inflammatory cytokine TNF-alpha has been shown in
cow-milk allergy in children and experimental food allergy in
mice [16, 17]. To the authors’ knowledge, no studies have
been performed characterizing the cytokine response to food
in dogs with CE. Determining the ex vivo whole blood cyto-
kine response to incubated food in these dogs, as well as
dogs presented for non-GI causes may help to determine if
there is a differential response within dogs with CE and
whether this corresponds with the cytokine response seen in
food allergy in humans and mice. The results from this study
may then lead to further studies to determine if this assay
could be used to help sub-classify dogs with CE into FRE,
SRE or GI food allergy. Therefore, the aim of our study was
to quantify the IL-10, TNF-alpha and IL-4 production fol-
lowing ex vivo incubation of whole blood with diets currently
being fed to dogs with confirmed or suspected CE and to
dogs presented for non-GI causes.
Methods
Dogs
Thirty-five dogs presenting to the University of Bristol Small
Animal Referral Hospital between December 1st 2017 and
August 31st 2018, with at least a three-week history of inter-
mittent or persistent GI signs were prospectively recruited
onto the study. The diagnostic investigations performed for
all dogs included a complete blood count, serum biochemis-
try panel, serum cobalamin and folate concentrations and
trans-abdominal ultrasound. The following investigations
were also performed in selected cases depending on
the history, physical examination and abdominal
ultrasound findings: pancreatic lipase immunoreac-
tivity, pancreatic trypsin like immunoreactivity, basal
cortisol, pre and post prandial bile acids, fecal para-
sitology using saturated zinc sulfate flotation, fecal
culture for Salmonella, Campylobacter and Clostrid-
ium difficile and collection of intestinal biopsies
using endoscopy. Dogs that had intestinal histopath-
ology performed that documented changes consistent
with CE were categorized as confirmed CE. Whereas,
dogs that had diagnostic investigations that ruled out
all known causes of chronic GI signs but did not
have intestinal histopathology to confirm CE were
categorized as suspected CE. Eighteen dogs present-
ing for non-GI related causes were also recruited
(Table 1).
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Exclusion criteria included dogs that were ultimately
diagnosed with or suspected to have GI neoplasia in the
GI group, dogs with current signs of dermatological or
chronic GI signs in the non-GI group and any dog re-
ceiving immunosuppressive doses of corticosteroids in
both the GI and non-GI group.
All owners were asked to bring in samples of currently
fed diets (10 g of dry or home-prepared food, ready to
feed or an unopened tin) to their appointment.
The University of Bristol granted ethical approval for
the study (VIN/17/008). Written and oral informed con-
sent was obtained from owners of all dogs that partici-
pated in the study.
Study protocol
Preparation of diets for use in ex vivo whole blood
stimulation assays
Similar to our previous study, a clean pestle and mortar
was used to grind ten grams of the relevant food with
sterile water and the mixture transferred to a 50mL
sterile tube1 [7]. The sterile tubes containing the mixture
were incubated for 2 to 12 h at 4-degrees on a rotator
and then centrifuged at 4000 rpm for 12min at room
temperature. The dietary supernatant was then filtered
using a 0.22-μm sterile filter2 in a sterile tissue culture
hood.3 The bicinchoninic assay4 was used to determine
the protein content of the filtrate and a working solution
Table 1 Demographics of dogs included in the study; including age, sex, neuter status, breed, diagnosis and diet(s) consumed
Confirmed CE (n = 22) Suspected CE (n = 9) Non-GI (n = 18)
Age (years); median
(range)
5 (0.7–10) 3.6 (0.5–11.8) 5.5 (0.5–10.7)
Sex,
neuter
status
M, MN 4, 6 1,5 7, 2
F, FN 4, 8 2,1 3,6
Breed (n) Crossbreeds (7), Labradors (3), Boxers
(2), Cocker spaniels (2), Bichon Frise (1),
German shepherd dog (1), Lowchen (1),
Chihuahua (1), Border collie (1), Cavalier
King Charles spaniel (1), Staffordshire
bull terrier (1) and Jack Russell terrier
(1).
Crossbreeds (3), Cocker spaniel (1),
West Highland White terrier (1),
Labrador (1), Jack Russell terrier (1),
Yorkshire terrier (1) and Springer
spaniel (1).
Crossbreeds (5), Miniature Schnauzers
(2), German shepherd dogs (2), Cavalier
king Charles spaniels (2), Labrador (1),
Staffordshire bull terrier (1), Bichon
Frise (1), Beagle (1), Husky (1), Whippet
(1) and Yorkshire terrier (1).
Diagnosis (n) Lymphoplasmacytic enteritis (5),
lymphoplasmacytic and eosinophilic
enteritis (4), eosinophilic enteritis (2),
eosinophilic colitis (2),
lymphoplasmacytic gastritis (2),
granulomatous colitis (1), plasmacytic
enteritis (1), lymphoplasmacytic colitis
(1), eosinophilic, plasmacytic and
mastocytic enteritis (1), lymphocytic
colitis (1), plasmacytic colitis (1) and
unremarkable partial thickness
endoscopic biopsies in a dog with
protein-losing enteropathy (1).
Suspected CE (9) Extra-hepatic portosystemic shunt (3),
asymptomatic idiopathic increases in
alkaline phosphatase activity (2),
sarcoma (2), urethral sphincter
mechanism incompetence (1),
neutrophilic bronchopneumonia (1),
primary hyperparathyroidism (1),
suspected hyperadrenocorticism (1),
nasal foreign body (1), chronic
bronchitis (1), suspected psychogenic
polydipsia (1), idiopathic seizure like
episodes (1), benign prostatic
hyperplasia with possible prostatitis (1),
pancreatitis (1) and eosinophilic
bronchopneumopathy (1).
Diet(s)
consumed
Commercial
intact
15 4 16
Hydrolyzed 4a 1 1
Home-
cooked
2 3 1
Commercial
intact +
Home-
cooked
2 1 0
Commercial
intact +
hydrolyzed
1 0 0
Three groups of dogs were included; dogs with confirmed chronic enteropathy (CE; n = 22), dogs with suspected CE (n = 9) and dogs with non-GI causes (n = 18). a
Includes two dogs that had previously been fed a hydrolyzed protein diet, which were also used in the assays for these two dogs, as the owners had provided
them at the appointment
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of 500 μg/mL was prepared using sterile phosphate buff-
ered saline5 (PBS). This concentration was chosen based
on the results of our previous study [7].
For owners feeding a combination of diets, if they were the
same diet type (see below) they were processed together
resulting in one dietary filtrate, otherwise they were proc-
essed separately. Three diet types were used in the study: 1)
a commercial intact protein diet, defined as either a com-
mercial over-the-counter diet or a commercial therapeutic
diet containing commonly fed ingredients (e.g. chicken, pork,
beef or ovine) or a commercial over the counter diet that
was labeled to contain less commonly fed ingredients, such
as turkey, salmon, venison, trout or duck; 2) a hydrolyzed
protein diet, defined as a commercial therapeutic hydrolyzed
diet; or 3) a home-prepared diet containing either chicken,
pork, salmon, cod, turkey or sardines. Unfortunately, no dogs
in the study were being fed a commercial therapeutic
limited-ingredient novel protein diet at the time of diagnosis.
All commercial therapeutic diets fed in this study were based
on European formulations and therefore would be dissimilar
to North American formulations of the same diet.
Whole blood stimulation assays
For each dog, residual blood from sampling for laboratory
testing as part of the diagnostic investigation was placed into
heparin and mixed with RPMI6 containing penicillin/strepto-
mycin7 in a 1:2 volume ratio and 1mL plated in a 24 well
plate8 within 1 h of collection. A negative control consisting
of 111 μL of PBS5 and 500 μg/mL of each diet type con-
sumed by the dog at the time of the appointment was added
to separate wells. All samples were analyzed in triplicates for
a total of 6 wells for dogs eating one diet type and a total of
9 wells for dogs eating two diet types. Similar to our previous
study, all plates were incubated at 37 degrees centigrade in
5% carbon dioxide for 24 h,9 after which time they were then
spun at 2000 × g for 4min and the supernatant collected
and stored at − 80 °C until analyzed [7].
The Canine TNF-alpha Quantikine ELISA Kit,10 Ca-
nine IL-10 Quantikine ELISA Kit,11 and Canine IL-4
DuoSet ELISA12 were used to quantify the concentra-
tions of TNF-alpha, IL-10, and IL-4 in the supernatants
according to the manufacturers’ instructions, respect-
ively. The triplicate cell culture wells were assayed indi-
vidually. A plate reader13 was used to measure optical
density at 450 nm with a 560 nm wavelength correction
within 30 min and the data were analyzed using a com-
puter software.14 The lower and upper concentrations of
the standard curve of the assays were 15.6 pg/mL and
1000 pg/mL for IL-10, 7.8 pg/mL and 500 pg/mL for
TNF-alpha and 93.75 pg/mL and 6000 pg/mL for IL-4.
All assays contained a positive control, which was pro-
vided by the manufacturer and a negative control, and
were performed in duplicate. The standard curve for all
plates yielded an R squared value of at least 0.96.
Data analysis
Similar to our previous study, the mean of each of the du-
plicate cytokine concentrations was calculated. The mean
of these values from the triplicate wells in the ex vivo
whole blood stimulation assay was then calculated for the
diet and standardized to PBS by subtraction [7].
A One-way analysis of variance (ANOVA) was used to
compare IL-10, TNF-alpha and IL-4 concentrations be-
tween commercial intact protein, hydrolyzed protein and
home-prepared diets in dogs with confirmed or sus-
pected CE. Post hoc analysis was performed using Bon-
ferroni correction. Independent-Samples T-tests were
used to compare IL-10, TNF-alpha and IL-4 concentra-
tions, as well as the IL-4:IL-10 and TNF-alpha:IL-10 be-
tween dogs with confirmed or suspected CE and dogs
presented for non-GI causes. Analyses were performed
using IBM SPSS Statistics Version 24. Significance was
defined as P < 0.05.
Results
Demographics of dogs with confirmed or suspected
chronic enteropathy and non-GI causes
Thirty-five dogs with chronic GI signs were recruited; 4
were excluded due to confirmed or suspected GI neopla-
sia. The final case group consisted of 22 dogs with CE
diagnosed on histopathology of GI biopsy and nine with
suspected CE (Table 1). The non-GI causes group con-
sisted of 18 dogs (Table 1).
Diet type and ex vivo whole blood stimulation assays in
dogs with confirmed or suspected CE
One-way ANOVA comparing the IL-10, TNF-alpha and
IL-4 concentrations between hydrolyzed protein diets
(n = 6), commercial intact protein diets (n = 24) and
home-prepared diets (n = 6) in dogs with suspected or
confirmed CE showed a significant difference for IL-10
and TNF-alpha concentrations, but not IL-4 concentra-
tions (P-values 0.005, < 0.001 and 0.125, respectively).
Post hoc analysis with Bonferroni showed that hydrolyzed
protein diets elicited significantly lower IL-10 and TNF-
alpha concentrations compared to commercial intact protein
diets in dogs with confirmed or suspected CE (IL-10: P-value
0.004; mean (standard deviation); hydrolyzed protein diet–
15.6 pg/mL (0); commercial intact protein diet – 413.66 pg/
mL (248.30), TNF-alpha: P-value < 0.001, hydrolyzed protein
diet – 8.18 pg/mL (0.94), commercial intact protein diet –
371.88 pg/mL (188.86)). However, there were no significant
differences in IL-4 concentrations between hydrolyzed protein
diets and commercial intact protein diets (P-value = 0.166, hy-
drolyzed protein diet – 98.36 pg/mL (11.3), commercial intact
protein diet – 490.7 pg/mL (473.9)). There were also no sig-
nificant differences in IL-10, TNF-alpha or IL-4 concentrations
between hydrolyzed protein diets and home-prepared diets
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(P-value > 0.220) and commercial intact protein diets and
home-prepared diets (P-value > 0.105) (Fig. 1).
Comparison of IL-10, TNF-alpha and IL-4 concentrations
between the two groups of dogs
Independent-Samples T-tests showed no significant differences
in IL-10, TNF-alpha or IL-4 concentrations between dogs with
confirmed or suspected CE and dogs with non-GI causes (P-
value 0.264, 0.858 and 0.834, respectively, mean (standard de-
viation); confirmed or suspected CE group vs. non-GI causes
group: IL-10 340.1 pg/mL (292.7) vs. 437.3 pg/mL (325.9),
TNF-alpha 297.5 pg/mL (219.2) vs. 286.0 pg/mL (239.4), IL-4
416.8 pg/mL (449.8) vs. 445.5 pg/mL (538.8), Fig. 2). Similarly,
there were no significant differences when comparing IL-10,
TNF-alpha or IL-4 between dogs with only confirmed CE and
non-GI causes (P-value 0.238, 0.785 and 0.934, respectively,
mean (standard deviation); confirmed CE group vs. non-GI
causes group: IL-10 324.5 pg/mL (305.3) vs. 437.3 pg/mL
(325.9), TNF-alpha 267.3 pg/mL (217.5) vs. 286.0 pg/mL
(239.4), IL-4 458.2 pg/mL (471.0) vs. 445.5 pg/mL (538.8).
Comparison of IL-4:IL-10 between dogs with confirmed
CE and dogs with non-GI causes
Independent-Samples T-tests showed no significant differ-
ences in IL-4:IL-10 between dogs with confirmed CE and
detectable IL-4 concentrations and dogs with non-GI
causes and detectable IL-4 concentrations (P-value 0.147,
confirmed CE: mean 10.25, standard deviation 22.36; non-
GI causes: mean 1.68, standard deviation 1.63). Six out of
the 15 dogs with detectable IL-4 concentrations in the
confirmed CE group had IL-4 to IL-10 ratios that
exceeded the 95% confidence interval (CI) of the mean of
the non-GI causes group (non-GI causes group: 95% CI of
IL-4:IL-10 = 0.64–2.71; confirmed CE group: IL-4:IL-10 in
6 dogs =mean 22.40, range 2.77–89.11, Fig. 3).
Comparison of TNF-alpha:IL-10 between dogs with
confirmed CE and dogs with non-GI causes
Independent-Samples T-tests showed no significant dif-
ferences in TNF-alpha:IL-10 between dogs with con-
firmed CE and TNF-alpha concentrations in the
detectable range and dogs with non-GI causes and TNF-
alpha concentrations in the detectable range (P-value
0.618, confirmed CE: mean 0.95, standard deviation 0.45;
non-GI causes: mean 0.75, standard deviation 1.13).
None of the 10 dogs with TNF-alpha concentrations
within the detectable range in the confirmed CE group
had TNF-alpha to IL-10 ratios that exceeded the 95%
confidence interval (CI) of the mean of the non-GI
causes group (non-GI causes group: 95% CI of TNF-
alpha:IL-10 = − 0.29-1.79; Fig. 4).
Discussion
Ex vivo whole blood stimulation assays have been previ-
ously used to characterize the cytokine response to hy-
drolyzed protein and commercial intact protein diets in
Fig. 1 Bar graph showing cytokine production following stimulation of ex vivo whole blood with different diet types in dogs with chronic
enteropathy. Bar graph of IL-10, TNF-alpha and IL-4 production following stimulation of ex vivo whole blood with hydrolyzed protein (6 dogs),
home-cooked (6 dogs) or commercial intact protein diets (24 dogs) in dogs with confirmed or suspected chronic enteropathy (CE). Hydrolyzed
protein diets elicited significantly lower IL-10 and TNF-alpha concentrations compared to commercial intact protein diets in dogs with confirmed
or suspected CE (P-value 0.004 and < 0.001, respectively)
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Fig. 2 Box and whisker plot showing cytokine production following stimulation of ex vivo whole blood with currently fed diets in dogs with CE
and non-GI causes. Box and whisker plot of IL-10, TNF-alpha and IL-4 production following stimulation of ex vivo whole blood with currently fed
diets in 18 dogs with non-GI causes and 31 dogs with confirmed or suspected CE. There were no significant differences in IL-10, TNF-alpha or IL-
4 concentrations between dogs with confirmed or suspected CE and dogs with non-GI causes (P-value 0.264, 0.858 and 0.834, respectively)
Fig. 3 Box and whisker plot showing IL-4 to IL-10 ratios following stimulation of ex vivo whole blood with currently fed diets in dogs with CE
and non-GI causes that had detectable IL-4 concentrations. Box and whisker plot of IL-4 to IL-10 ratios following stimulation of ex vivo whole
blood with currently fed diets in 12 dogs with non-GI causes and 16 dogs with confirmed CE that had detectable IL-4 concentrations. There were
no significant differences in IL-4:IL-10 between the two groups (P-value 0.147)
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individual, healthy, immunotolerant cats [7]. The major-
ity of these healthy, immunotolerant cats produced de-
tectable IL-10 concentrations but undetectable TNF-
alpha and IL-4 concentrations when their ex vivo whole
blood was stimulated with commercial intact protein
diet that they had previously tolerated, suggesting that
IL-10 may be useful as a marker for dietary tolerance
[7]. Conversely, studies in humans and mice with food
allergy have demonstrated increased IL-4 and TNF-
alpha and decreased IL-10 concentrations [12–14, 16–
19]. Therefore, our study aimed to characterize the re-
sponse of these 3 cytokines to currently fed diets follow-
ing incubation with ex vivo whole blood in dogs with CE
and non-GI causes to help further characterize the
pathogenesis of diet in CE.
Our study showed that there were no significant differ-
ences in IL-10, TNF-alpha and IL-4 concentrations be-
tween dogs with confirmed or suspected CE and dogs
with non-GI causes. Although the IL-4 to IL-10 ratios
were not significantly different between dogs with con-
firmed CE and dogs with non-GI causes, nearly half of
dogs with detectable IL-4 concentrations in the con-
firmed CE group (approximately a quarter of all dogs
with confirmed CE) had IL-4:IL-10 above the 95% confi-
dence interval of the mean of the non-GI group. The
lack of significance of any of the cytokines or their ratios
between the two groups in our study may be due to the
heterogeneity of disease pathogenesis in the dogs with
confirmed CE. Chronic enteropathy is an idiopathic dis-
ease that is diagnosed by exclusion of all known causes
of chronic GI inflammation and the confirmation of in-
flammatory and architectural changes on intestinal
histopathology [20]. Approximately 50 to 60% of dogs
with CE respond to dietary changes [21, 22]. However,
most dogs with CE can be transitioned back to their ori-
ginal diet without showing any relapse. In one study, 8%
of dogs with GI signs relapsed on challenge [2]; therefore
these cases were likely food allergic or had a significant
dietary risk factor for the development of their CE that
triggered a relapse. Gastrointestinal food allergy can be
subdivided into 2 major categories; IgE-mediated, which
involves mainly mast cells and non-IgE mediated, mainly
involving T-cells and eosinophils [4]. Although the incit-
ing factors for GI food allergy are not well characterized,
studies have shown the pathogenesis to be mediated by
a Th2 immune response to food allergens [23]. Severe
infiltration of CD4+ T cells and over production of the
Th2 cytokines, including IL-4, IL-5 and IL-13 have been
documented in the intestinal mucosa of humans and
mouse models of GI food allergy [24, 25]. Studies have
also shown increased IL-4 secreting T-cells in PBMCs
isolated from humans with food allergy compared to
Fig. 4 Box and whisker plot showing TNF-alpha to IL-10 ratios following stimulation of ex vivo whole blood with currently fed diets in dogs with
CE and non-GI causes that had TNF-alpha concentrations within the detectable range. Box and whisker plot of TNF-alpha to IL-10 ratios following
stimulation of ex vivo whole blood with currently fed diets in 7 dogs with non-GI causes and 10 dogs with confirmed CE that had TNF-alpha
concentrations within the detectable range. There were no significant differences in TNF-alpha:IL-10 between the two groups (P-value 0.618)
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control patients [26–28]. Some studies have also docu-
mented decreased T-regulatory cells in humans with
food allergy, suggesting this may be the reason for the
documented decreased IL-10 and increased IL-4 concen-
trations in these patients [29–32]. Although the conse-
quences of the Th2 immune response is well characterized
in food allergy, the causative factors for this response are not
yet fully known. However, these patients may have a genetic
risk factor, as polymorphisms in the IL-10 and IL-4 gene
have been shown to have multiple associations with allergic
sensitization [33]. Dogs with CE and GI food allergy may
have overlapping clinical signs. Unfortunately, at this time
the definitive differentiation of these two conditions in dogs
is not possible. Although, the return of clinical signs follow-
ing challenge with the original diet suggests food allergy, CE
can not be definitively ruled out as these dogs may also re-
lapse due to individual dietary risk factors. Therefore, the ab-
solute proportion of dogs with confirmed or suspected CE in
our study that had CE, GI food allergy or both is not known.
The 6 dogs with confirmed CE and IL-4:IL-10 above the
95% CI of the mean of the non-GI group had a cytokine pro-
file that may suggest a GI food allergy based on the studies
performed in human and mouse models of GI food allergy.
However, follow-up on all the dogs with CE to determine if
their clinical signs completely responded to dietary manage-
ment and results of any subsequent challenge trials would be
needed to determine if IL-4:IL-10 could be useful to differen-
tiate GI food allergy from CE. Similarly, treatment follow-up
on all the dogs with CE may also help to determine if the
cytokine response can help differentiate FRE from SRE.
Other possible reasons for the lack of significance in
cytokine production between the confirmed or suspected
CE and non-GI group could be due to the limited num-
ber of dogs included in each group resulting in the study
being under powered. Also, the non-GI causes group
contained 5 dogs with a peripheral eosinophilia at the
time of sampling, which may have been an indication of
an underlying food allergy, as non-GI signs can be mani-
festations of this disease. However, none of the dogs had
current signs of cutaneous food allergy. Therefore, if
these 5 dogs in the non-GI group also had a food allergy,
this may have explained the lack of significance between
the two groups. Another possible reason included not
sampling treats that owners may have been feeding at
the time of diagnosis to determine the cytokine response
and therefore any adverse reactions to these additional
foods would have been missed in the confirmed or sus-
pected CE group and may have resulted in a lack of sig-
nificant difference between the two groups.
Antigen primed lymphocytes circulate via the mesen-
teric lymph node, chyle and blood stream back to the in-
testinal lamina propria [34]. Therefore, our study used
whole blood as a surrogate for immunological responses
to diet at the intestinal lamina propria due to the
circulation of these primed lymphocytes. Intact rather
than enzymatically digested food was used to stimulate
whole blood in our study so that proteins retained their
antigenicity. Dietary proteins implicated in food allergy
are those that survive or bypass digestion within the
gastrointestinal tract and present intact to the immune
cells in the gut [35, 36]. This is further demonstrated by
the fact that antibodies to whole dietary proteins can be
found in allergic as well as healthy animals [37–39]. How-
ever, whether there is an allergic reaction to the whole
dietary protein depends on the class of antibody and
whether there is an immune response, for example cyto-
kine secretion or lymphocyte proliferation [40]. The intes-
tinal mucosal surface may be able to dampen any pro-
inflammatory responses to diet due to additional homeo-
static immunological pathways that may be absent in the
peripheral blood. This may explain why several diets in
our study elicited cytokine production when incubated
with ex vivo whole blood. In addition, as intact diets were
incubated with whole blood, some of these intact proteins
may be very easily digested in the gastrointestinal tract
and therefore might never have presented intact to the im-
mune cells within the gut in these dogs and may therefore
elicit a pro-inflammatory rather than a systemic homeo-
static immunological response. Therefore, confirmation of
cytokine response to currently fed diets at the intestinal
mucosal level is needed in dogs with CE to determine the
clinical significance of our findings, as well as to confirm
whether ex vivo whole blood could act as an appropriate
surrogate for immunological responses to diet at the intes-
tinal mucosal surface. Also, determining the effect of mild
and moderate enzymatic digestion of the diet on cytokine
response at the systemic and intestinal mucosal surface in
dogs with CE may also be warranted.
Our study showed that hydrolyzed protein diets elic-
ited significantly lower IL-10 and TNF-alpha concentra-
tions compared to commercial intact protein diets in
dogs with confirmed or suspected CE. This is similar to
the cytokine response seen following stimulation of ex
vivo whole blood with hydrolyzed protein diets in
healthy immunotolerant cats [7]. Hydrolyzed protein di-
ets have been successfully used in the management of
CE in dogs [41, 42] and our study suggests that one
mechanism for their effectiveness may be because of
their ability to stimulate less cytokine production. Hy-
drolyzed protein diets contain peptides that are theoret-
ically small enough to avoid an IgE meditated food
allergy, by preventing cross-linking of two IgE antibody
receptors on a mast cell. Although, the size of peptide
needed to avoid a non-IgE mediated food allergy in dogs
is currently unknown, the smaller size of the peptide in
hydrolyzed protein diets is the likely reason why they
elicit a reduced cytokine response. However, further
studies are needed to confirm the exact mechanism of
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the beneficial effects of hydrolyzed protein diets in CE,
as well as to confirm the cytokine response to these diets
at the intestinal mucosal surface.
Other limitations of our study, in addition to the inclusion
of 5 dogs with a peripheral eosinophilia in the non-GI causes
group at the time of sampling and not including treats that
owners may have been feeding at the time of diagnosis to de-
termine the cytokine response include, not standardizing the
lymphocyte count per well for each animal and not taking
into consideration the presence of antibodies to food, al-
though the effect of these on cytokine production to crude
extracts of food is unknown. Another limitation included
not definitively being able to rule out the presence of pattern
recognition receptor ligands in the diet extracts, although all
diet samples were processed the same way and using the
same equipment including a sterile tissue culture hood and
sterile filters. Also, the fact that the majority of hydrolyzed
protein diets elicited undetectable pro-inflammatory cyto-
kines following stimulation with ex vivo whole blood sug-
gests that the technique used to process and sterilize the
diets did not introduce significant bacterial contamination.
Finally, although data regarding the intra-assay and
inter-assay precision, recovery and linearity of the Ca-
nine TNF-alpha and IL-10 Quantikine ELISAs with cell
culture supernatants have been validated by the manu-
facturer, in-house validation by the authors for intra-
assay and inter-assay coefficient of variation, parallelism,
and spike-recoveries for all cytokine assays was not spe-
cifically performed. Therefore, another potentially ser-
ious limitation of our study is the absence of in-house
validation of commercially available and widely used ca-
nine cytokine assays and therefore this could lead to in-
accurate or artifactual results. However, any inaccuracies
would be expected to affect all groups equally and the
standard curves for all ELISAs in our study yielded an R
squared value of at least 0.96, and positive and negative
controls were utilized for each assay and all samples
were assayed in duplicates following stimulation of trip-
licate wells. Nevertheless, futures studies should aim to
address this limitation by ensuring that all commercial
canine cytokine assays are not just validated by the
manufacturer but also in-house.
Conclusion
In conclusion, our study showed that hydrolyzed protein di-
ets elicited a significantly reduced cytokine response when
incubated with patient whole blood ex vivo compared to
commercial intact protein diets in dogs with CE. As approxi-
mately a quarter of the dogs with confirmed CE had IL-4 to
IL-10 ratios higher than 95% of the CI of the mean in dogs
with non-GI causes, this ratio as a marker of dietary respon-
siveness warrants further investigation. Similarly, studies
assessing the cytokine response to diet at the intestinal mu-
cosal surface in dogs with CE are needed.
Endnotes
150 mL Sterile Centrifuge Tubes. Corning®. Corning
Incorporated, Corning, NY.
2Minisart® NML Syringe Filter, 16,534 0.2 μm,
Surfactant-free Cellulose Acetate. Sartorius Corporate
Administration GmbH, Goettingen, Germany
3Sterile culture hood, Jouan LC2.12.
4Pierce® BCA Protein Assay Kit, ThermoFischer Scien-
tific, Hemel Hempstead, UK.
5PBS, Fischer, Scientific Loughborough, UK.
6RPMI Medium 1640, ThermoFischer Scientific.
7Penicillin-Streptomycin Solution, Sigma-Aldrich
Company Ltd., Gillingham, Dorset.
8Corning Costar®24 Well Plate, individually wrapped,
sterile.
9Sanyo CO2, Model MCO-15 AC.
10Canine TNF-alpha Quantikine ELISA Kit, R&D Sys-
tems, Inc. Abingdon, UK.
11Canine IL-10 Quantikine ELISA Kit, R&D Systems,
Inc.
12Canine IL-4 DuoSet ELISA, R&D Systems, Inc.
13Labsystems Multiskan EX Reader.
14Genesis Reader and Imager Software. Genesis Inc.
1998.
Abbreviations
Ig: immunoglobulin; IL: interleukin; PBMC: peripheral blood mononuclear
cells; PBS: phosphate buffered saline; RPMI: Roswell Park Memorial Institute;
TNF: tumor necrosis factor
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